tradingkey.logo

enVVeno Medical Corp

NVNO

0.933USD

-0.002-0.16%
收盤 09/19, 16:00美東報價延遲15分鐘
17.96M總市值
虧損本益比TTM

enVVeno Medical Corp

0.933

-0.002-0.16%
關於 enVVeno Medical Corp 公司
enVVeno Medical Corporation 是一家後期臨牀醫療技術公司。該公司專注於生物假體(組織型)解決方案的進步,以提高靜脈疾病治療的護理標準。該公司正在爲患有腿部深靜脈系統嚴重慢性靜脈功能不全 (CVI) 的患者開發手術和非手術置換靜脈瓣膜。該公司的主打產品 VenoValve 是一種基於豬的置換靜脈瓣膜,通過手術植入腿部深靜脈系統以治療嚴重的 CVI。VenoValve 是通過大腿上部 5 到 6 英寸的切口在開放式手術中植入患者的股靜脈的。VenoValve 正在美國外科抗反流靜脈瓣膜內置假體 (SAVVE) 臨牀試驗中進行評估。該公司還在開發第二種產品 enVVe,這是一種非手術、經導管置換靜脈瓣膜。
公司簡介
公司代碼NVNO
公司名稱enVVeno Medical Corp
上市日期May 31, 2018
CEOMr. Robert A. Berman
員工數量37
證券類型Ordinary Share
年結日May 31
公司地址70 Doppler
城市IRVINE
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編92618
電話19492612900
網址https://envveno.com/
公司代碼NVNO
上市日期May 31, 2018
CEOMr. Robert A. Berman
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Francis Duhay
Dr. Francis Duhay
Independent Director
Independent Director
97.44K
-4.79%
Mr. Robert C. Gray
Mr. Robert C. Gray
Independent Director
Independent Director
10.36K
-7.17%
Dr. Sanjay Shrivastava
Dr. Sanjay Shrivastava
Independent Director
Independent Director
9.29K
--
Dr. Marc H. Glickman, M.D.
Dr. Marc H. Glickman, M.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
1.60K
--
Dr. Hamed Alavi
Dr. Hamed Alavi
Senior Vice President, Chief Technology Officer
Senior Vice President, Chief Technology Officer
--
--
Mr. Matthew M. Jenusaitis
Mr. Matthew M. Jenusaitis
Independent Director
Independent Director
--
--
Mr. Robert A. Berman
Mr. Robert A. Berman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Jennifer Bright
Ms. Jennifer Bright
Chief Financial Officer
Chief Financial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Francis Duhay
Dr. Francis Duhay
Independent Director
Independent Director
97.44K
-4.79%
Mr. Robert C. Gray
Mr. Robert C. Gray
Independent Director
Independent Director
10.36K
-7.17%
Dr. Sanjay Shrivastava
Dr. Sanjay Shrivastava
Independent Director
Independent Director
9.29K
--
Dr. Marc H. Glickman, M.D.
Dr. Marc H. Glickman, M.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
1.60K
--
Dr. Hamed Alavi
Dr. Hamed Alavi
Senior Vice President, Chief Technology Officer
Senior Vice President, Chief Technology Officer
--
--
Mr. Matthew M. Jenusaitis
Mr. Matthew M. Jenusaitis
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 8月23日 週六
更新時間: 8月23日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Kingdon Capital Management, L.L.C.
7.06%
Perceptive Advisors LLC
6.68%
The Vanguard Group, Inc.
3.63%
Nantahala Capital Management, LLC
3.09%
Westside Investment Management, LLC
1.45%
其他
78.09%
持股股東
持股股東
佔比
Kingdon Capital Management, L.L.C.
7.06%
Perceptive Advisors LLC
6.68%
The Vanguard Group, Inc.
3.63%
Nantahala Capital Management, LLC
3.09%
Westside Investment Management, LLC
1.45%
其他
78.09%
股東類型
持股股東
佔比
Hedge Fund
11.63%
Investment Advisor
7.83%
Private Equity
6.81%
Investment Advisor/Hedge Fund
2.66%
Research Firm
1.12%
Individual Investor
0.81%
Venture Capital
0.09%
其他
69.05%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
75
3.80M
19.76%
-3.06M
2025Q1
73
3.82M
21.80%
-3.21M
2024Q4
75
4.44M
25.31%
-1.95M
2024Q3
71
5.27M
30.14%
+688.15K
2024Q2
65
3.79M
29.68%
-1.51M
2024Q1
67
4.10M
32.04%
-789.97K
2023Q4
59
4.71M
36.59%
+2.14M
2023Q3
57
2.68M
28.24%
-1.00M
2023Q2
55
2.71M
28.61%
-1.36M
2023Q1
54
2.76M
29.13%
-1.37M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Kingdon Capital Management, L.L.C.
859.26K
4.9%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
600.91K
3.43%
+11.77K
+2.00%
Mar 31, 2025
Nantahala Capital Management, LLC
594.66K
3.39%
-2.26K
-0.38%
Mar 31, 2025
Westside Investment Management, LLC
259.05K
1.48%
+54.02K
+26.35%
Mar 31, 2025
UBS O'Connor LLC
296.03K
1.69%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
197.30K
1.13%
+15.56K
+8.56%
Mar 31, 2025
J.P. Morgan Securities LLC
194.21K
1.11%
-75.83K
-28.08%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Nov 27, 2020
Merger
25→1
Nov 27, 2020
Merger
25→1
Nov 27, 2020
Merger
25→1
Nov 27, 2020
Merger
25→1
公告日期
類型
比率
Nov 27, 2020
Merger
25→1
Nov 27, 2020
Merger
25→1
Nov 27, 2020
Merger
25→1
Nov 27, 2020
Merger
25→1
KeyAI